BHBetty Lee-Sue Ho

Betty Lee-Sue Ho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Betty Lee-Sue Ho has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Azly Sumanty Ab Ghani

    Department of Pathology Hospital Sultanah Nur Zahirah, Ministry of Health Terengganu Malaysia

    2 shared publications
  • Durar Aqilah Zamri

    Genetics Department Hospital Tunku Azizah, Ministry of Health Kuala Lumpur Malaysia

    2 shared publications
  • Ezalia Esa

    Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health, Selangor, Malaysia

    2 shared publications
  • Muhamad Farid Zulkifle

    Cancer Research Centre Institute for Medical Research, National Institutes of Health, Ministry of Health Selangor Malaysia

    2 shared publications
  • Nazzlin Dizana Din

    Department of Pediatrics Hospital Sultanah Nur Zahirah, Ministry of Health Terengganu Malaysia

    2 shared publications
  • Nor Rizan Kamaluddin

    Cancer Research Centre Institute for Medical Research, National Institutes of Health, Ministry of Health Selangor Malaysia

    2 shared publications

Latest Publications

  • Open Access

    Single Nucleotide Polymorphism Microarray Analysis Unveils Copy‐Number Abnormalities and Genetic Heterogeneity in Malaysian Childhood B‐Cell Precursor Acute Lymphoblastic Leukemia

    by Nor Soleha Mohd Dali, Nursaedah Abdullah Aziz, Muhamad Farid Zulkifle, Durar Aqilah Zamri, Nor Rizan Kamaluddin, Seoh‐Leng Yeoh, Betty Lee‐Sue Ho, Nazzlin Dizana Din, Azly Sumanty Ab Ghani, Wan Amal Hayati Wan Hassan, et al.

    Introduction: B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL) is a prevalent pediatric hematologic malignancy characterized by diverse chromosomal aberrations that significantly influence its prognosis. This study aimed to comprehensively characterize the genomic landscape of BCP‐ALL in 55 Malaysian patients with BCP‐ALL. Methods: Single‐nucleotide polymorphism (SNP) 6.0 microarray and multiplex ligation‐dependent probe amplification were utilized to characterize and validate copy‐number abnormalities involving key oncogenes, respectively. Results: The SNP 6.0 microarray identified 191 copy‐number abnormalities in 55 patients, including common subtypes such as hyperdiploidy ( n = 14/191, 7.3%), hypodiploidy ( n = 2/191, 1.1%), and various copy‐number abnormalities such as interstitial (23.0%), terminal (17.2%), focal (37.1%), and intragenic (18.0%). Notably, intrachromosomal amplification of chromosome 21 (iAMP21) was not observed, suggesting its rarity in this cohort. Comparison with conventional cytogenetic techniques, including Trypsin‐Leishman's banding karyotyping, fluorescent in situ hybridization (FISH), and reverse transcription‐polymerase chain reaction (RT‐PCR), revealed superior resolution of the SNP 6.0 microarray in detecting submicroscopic copy‐number abnormalities. Furthermore, MLPA confirmed abnormalities in several oncogenes, including CDKN2A/B , EBF1 , ERG , ETV6 , IKZF1 , JAK2 , and PAX5 . Conclusion: This study demonstrates the utility of combined SNP 6.0 microarray and MLPA in providing a comprehensive and refined understanding of the genetic landscape of BCP‐ALL in the Malaysian population. This understanding may facilitate risk stratification and the development of personalized treatment strategies.

    • 1 March 2026
      • Vol. 14  (3) , e70182
    Open Access

    Single Nucleotide Polymorphism Microarray Analysis Unveils Copy-Number Abnormalities and Genetic Heterogeneity in Malaysian Childhood B-Cell Precursor Acute Lymphoblastic Leukemia.

    by Nor Soleha Mohd Dali, Nursaedah Abdullah Aziz, Muhamad Farid Zulkifle, Durar Aqilah Zamri, Nor Rizan Kamaluddin, Seoh-Leng Yeoh, Betty Lee-Sue Ho, Nazzlin Dizana Din, Azly Sumanty Ab Ghani, Wan Amal Hayati Wan Hassan, et al.

    B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is a prevalent pediatric hematologic malignancy characterized by diverse chromosomal aberrations that significantly influence its prognosis. This study aimed to comprehensively characterize the genomic landscape of BCP-ALL in 55 Malaysian patients with BCP-ALL. Single-nucleotide polymorphism (SNP) 6.0 microarray and multiplex ligation-dependent probe amplification were utilized to characterize and validate copy-number abnormalities involving key oncogenes, respectively. The SNP 6.0 microarray identified 191 copy-number abnormalities in 55 patients, including common subtypes such as hyperdiploidy (n = 14/191, 7.3%), hypodiploidy (n = 2/191, 1.1%), and various copy-number abnormalities such as interstitial (23.0%), terminal (17.2%), focal (37.1%), and intragenic (18.0%). Notably, intrachromosomal amplification of chromosome 21 (iAMP21) was not observed, suggesting its rarity in this cohort. Comparison with conventional cytogenetic techniques, including Trypsin-Leishman's banding karyotyping, fluorescent in situ hybridization (FISH), and reverse transcription-polymerase chain reaction (RT-PCR), revealed superior resolution of the SNP 6.0 microarray in detecting submicroscopic copy-number abnormalities. Furthermore, MLPA confirmed abnormalities in several oncogenes, including CDKN2A/B, EBF1, ERG, ETV6, IKZF1, JAK2, and PAX5. This study demonstrates the utility of combined SNP 6.0 microarray and MLPA in providing a comprehensive and refined understanding of the genetic landscape of BCP-ALL in the Malaysian population. This understanding may facilitate risk stratification and the development of personalized treatment strategies.